🇺🇸 FDA
Patent

US 11028162

Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties

granted A61PA61P35/00A61P43/00

Quick answer

US patent 11028162 (Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties) held by The Regents of the University of California expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P35/00, A61P43/00, A61P9/00